Bridgeway Capital Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-95,963
| Closed | -$54K | – | 1200 |
|
|
2024
Q4 | $54K | Sell |
95,963
-32,037
| -25% | -$18K | ﹤0.01% | 1151 |
|
|
2024
Q3 | $76.8K | Hold |
128,000
| – | – | ﹤0.01% | 1179 |
|
|
2024
Q2 | $346K | Buy |
128,000
+21,500
| +20% | +$58.1K | 0.01% | 940 |
|
|
2024
Q1 | $546K | Buy |
+106,500
| New | +$546K | 0.01% | 900 |
|
|
2023
Q4 | – | Sell |
-56,500
| Closed | -$37.4K | – | 1375 |
|
|
2023
Q3 | $37.4K | Hold |
56,500
| – | – | ﹤0.01% | 1324 |
|
|
2023
Q2 | $85.9K | Hold |
56,500
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q1 | $107K | Sell |
56,500
-78,000
| -58% | -$148K | ﹤0.01% | 1225 |
|
|
2022
Q4 | $127K | Hold |
134,500
| – | – | ﹤0.01% | 1183 |
|
|
2022
Q3 | $152K | Sell |
134,500
-22,000
| -14% | -$24.9K | ﹤0.01% | 1191 |
|
|
2022
Q2 | $219K | Buy |
156,500
+100,000
| +177% | +$140K | 0.01% | 1075 |
|
|
2022
Q1 | $142K | Buy |
+56,500
| New | +$142K | ﹤0.01% | 1227 |
|